Starting January 1, 2026, Medicare's negotiated prices for the first 10 Part D drugs take effect, lowering what a parent pays for medicines like Eliquis, Jardiance, and Xarelto, per CMS. The Inflation Reduction Act also caps insulin at $35 for a month's supply, makes recommended adult vaccines $0, and holds a parent's total Part D out-of-pocket costs to $2,100 in 2026. Together these changes can substantially cut a parent's yearly drug spending.
Saving money
How the Inflation Reduction Act Drug Price Negotiations Affect a Parent's Part D Costs (2026)
By Chuck Brodsky, Co-Founder, MediNav · Updated July 2026 · 7 min read
✓ Every figure checked against official sources. How we keep this accurate →
Quick answer
If your parent takes several prescriptions, 2026 is the year the Inflation Reduction Act's drug-pricing changes fully arrive. Knowing which changes apply helps you check that your parent is actually getting the lower costs they are owed.
The first negotiated prices begin in 2026
For the first time, Medicare negotiated prices directly with drug makers, and the negotiated prices for 10 widely used Part D drugs take effect January 1, 2026, per CMS. The list includes common blood thinners, diabetes drugs, and heart-failure medicines — among them Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, and Enbrel. If your parent takes one of these, their plan should reflect the lower negotiated price; check the plan's 2026 drug pricing to confirm.
Insulin is capped at $35 a month
Under the Inflation Reduction Act, a one-month supply of each Part D-covered insulin costs a parent no more than $35, per Medicare. That cap applies to everyone with Part D coverage, even a parent who also gets Extra Help. There is no separate deductible for insulin. If your parent is billed more than $35 for a month's insulin, that is a red flag to raise with the plan or pharmacy.
Recommended vaccines are free
Adult vaccines recommended by the CDC's advisory committee — including the shingles and other common vaccines — carry $0 cost-sharing under Part D, per Medicare, with no copay and no deductible. This is a real, easy saving: a parent should never pay out of pocket for a covered recommended vaccine, so confirm the pharmacy bills it correctly.
The $2,100 out-of-pocket cap ties it together
The single biggest protection is the annual out-of-pocket cap: once a parent's out-of-pocket spending on covered Part D drugs reaches $2,100 in 2026, they pay $0 for covered drugs the rest of the year, per CMS. This replaced the old coverage gap. For a parent on expensive drugs, it puts a firm ceiling on the year — see the Part D $2,100 cap explained and, if costs land early in the year, the Medicare Prescription Payment Plan.
What a caregiver should do
Check your parent's 2026 plan against their actual drug list: confirm any negotiated drug reflects the lower price, that insulin is no more than $35 a month, that recommended vaccines cost $0, and that the plan tracks toward the $2,100 cap. Qualifying for Extra Help lowers costs further. These are benefits a parent is owed, so it is worth verifying they show up.
When to call MediNav
- Free: Ask a specific question — tell us your parent's drugs and get a straight answer on what the 2026 changes save them.
- Free: Run the coverage check — in about two minutes, see what a parent is likely eligible for with 2026 figures for your state.
- Paid ($9–$19/mo): MediNav Watch and Watch+ re-check the figures as they change each year and remind you before deadlines, so nothing lapses unnoticed.
Related guides
- The Part D $2,100 Out-of-Pocket Cap, the annual ceiling on drug costs
- Medicare Prescription Payment Plan (M3P), spread costs across the year
- Does the Donut Hole Still Exist?, what replaced the coverage gap
- What Is Extra Help?, the subsidy that lowers costs further
Frequently asked questions
What if my parent takes one of the negotiated drugs?
Starting January 1, 2026, their Part D plan should reflect Medicare's lower negotiated price for that drug. The first 10 include Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, and others. Check the plan's 2026 pricing for the drug, and if the price does not look lower, ask the plan why.
How much does insulin cost under Medicare in 2026?
A one-month supply of each Part D-covered insulin costs no more than $35, per Medicare, and the cap applies even with Extra Help. There is no separate insulin deductible. If a pharmacy charges your parent more than $35 for a month's insulin, raise it with the plan right away.
Are vaccines really free for my parent?
Yes. Adult vaccines recommended by the CDC's advisory committee carry $0 cost-sharing under Part D — no copay, no deductible — per Medicare. The shingles vaccine is the common example. A parent should not pay out of pocket for a covered recommended vaccine, so confirm the pharmacy processes it as a Part D vaccine.
What is the most a parent will pay for drugs in 2026?
Out-of-pocket spending on covered Part D drugs is capped at $2,100 for 2026, per CMS. Once a parent reaches that amount, they pay $0 for covered drugs for the rest of the year. Premiums are separate and do not count toward the cap.
Do these savings apply to Medicare Advantage drug coverage?
Yes. The Inflation Reduction Act changes apply to Part D coverage whether it is a standalone drug plan or built into a Medicare Advantage plan. The negotiated prices, the $35 insulin cap, free recommended vaccines, and the $2,100 out-of-pocket cap all apply to a parent's Part D drug coverage either way.
What if my parent still can't afford their drugs?
Apply for Extra Help, the Part D low-income subsidy, which lowers premiums, deductibles, and copays on top of these changes. Also ask the plan about the Medicare Prescription Payment Plan to spread costs across the year. Between these tools and the $2,100 cap, most parents can bring drug spending to a manageable level.
Sources: CMS — Negotiated prices for initial price applicability year 2026, Medicare.gov — Insulin, CMS — Final CY2026 Part D Redesign. Last verified July 2026.